Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass

Anesthesiology

Volumn 122, Issue 4, 2015, Pages 746-758

  Wesley, Mark C ^a   Pereira, Luis M ^a   Scharp, Laurie A ^a   Emani, Sitaram M ^a   McGowan, Francis X ^b   Dinardo, James A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADOLESCENT; AGE DISTRIBUTION; ARTERIAL FILTER; BLOOD RESERVOIR; BODY SURFACE; BODY TEMPERATURE; BODY WEIGHT; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS EQUIPMENT; CHILD; CLINICAL TRIAL; COMPARTMENT MODEL; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INFUSION; FEMALE; HEART SURGERY; HEMOCONCENTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; INTRAVENOUS CATHETER; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGENATOR; PEDIATRIC ANESTHESIA; PEDIATRIC CARDIOLOGY; PEDIATRIC SURGERY; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SIMULATION; SURGICAL PATIENT; ULTRAFILTRATION; BIOLOGICAL MODEL; COHORT ANALYSIS; PRESCHOOL CHILD; PROCEDURES;

ANTIFIBRINOLYTIC AGENTS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; TRANEXAMIC ACID;

EID: 84932082279     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000570     Document Type: Conference Paper

References (24)

1. Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA: The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997; 84:990-6
2. Chauhan S, Das SN, Bisoi A, Kale S, Kiran U: Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18:141-3
3. Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP: Comparative analysis of antifibrinolytic medications in pediatric heart surgery. J Thorac Cardiovasc Surg 2012; 143:550-7
4. Chauhan S, Bisoi A, Kumar N, Mittal D, Kale S, Kiran U, Venugopal P: Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2004; 12:121-4
5. Couturier R, Rubatti M, Credico C, Louvain-Quintard V, Anerkian V, Doubine S, Vasse M, Grassin-Delyle S: Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2014; 25:259-65
6. Eaton MP: Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008; 106:1087-100
7. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL: The dose-response relationship of tranexamic acid. Anest hes iology 1995; 82:383-92
8. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J: Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anest hes iology 2002; 97:390-9
9. Grassin-Delyle S, Tremey B, Abe E, Fischler M, Alvarez JC, Devillier P, Urien S: Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2013; 111:916-24
10. Sigaut S, Tremey B, Ouattara A, Couturier R, Taberlet C, Grassin-Delyle S, Dreyfus JF, Schlumberger S, Fischler M: Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anest hes iology 2014; 120:590-600
11. Yee BE, Wissler RN, Zanghi CN, Feng C, Eaton MP: The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro. Anesth Analg 2013; 117:767-72
12. Soslau G, Horrow J, Brodsky I: Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991; 38:113-9
13. Stief T: Effect of tranexamic acid on mortality in patients with traumatic bleeding: Prespecified analysis of data from randomised controlled trial. Tranexamic acid might stop severe bleeding by intrinsic generation of thrombin. BMJ 2012; 345: e5839
14. Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF: Efficacy of tranexamic acid in pediatric craniosynostosis surgery: A double-blind, placebocontrolled trial. Anest hes iology 2011; 114:862-71
15. Eriksson O, Kjellman H, Pilbrant A, Schannong M: Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol 1974; 7:375-80
16. Ririe DG, James RL, O'Brien JJ, Lin YA, Bennett J, Barclay D, Hines MH, Butterworth JF: The pharmacokinetics of epsilonaminocaproic acid in children undergoing surgical repair of congenital heart defects. Anesth Analg 2002; 94:44-9
17. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S: A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anest hes iology 2013; 118:853-62
18. Björkman S, Oh M, Spotts G, Schroth P, Fritsch S, Ewenstein BM, Casey K, Fischer K, Blanchette VS, Collins PW: Population pharmacokinetics of recombinant factor VIII : The relationships of pharmacokinetics to age and body weight. Blood 2012; 119:612-8
19. Bojko B, Vuckovic D, Mirnaghi F, Cudjoe E, Wasowicz M, Jerath A, Pawliszyn J: Therapeutic monitoring of tranexamic acid concentration: High-throughput analysis with solidphase microextraction. Ther Drug Monit 2012; 34:31-7
20. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M: High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110:350-3
21. Schwinn DA, Mackensen GB, Brown EN: Understanding the TXA seizure connection. J Clin Invest 2012; 122:4339-41
22. Koster A, Börgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U: Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: Incidence and clinical outcome. Br J Anaesth 2013; 110:34-40
23. Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F: High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012; 93:148-54
24. Bellinger DC, Wypij D, Rivkin MJ, DeMaso DR, Robertson RL Jr, Dunbar-Masterson C, Rappaport LA, Wernovsky G, Jonas RA, Newburger JW: Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: Neuropsychological assessment and structural brain imaging. Circulation 2011; 124:1361-9